Vaccines

Influenza Vaccine in Elderly Adults: Is High-Dose Better Than Standard-Dose?

Influenza Vaccine in Elderly Adults: Is High-Dose Better Than Standard-Dose?

By

A higher dose of the flu vaccine provided better protection against respiratory and all-cause hospital admissions.

ACIP Issues New Influenza Guidelines for 2017-2018

ACIP Issues New Influenza Guidelines for 2017-2018

By

The ACIP issued new guidelines for the upcoming influenza season including not using live attenuated influenza vaccine because of concerns of effectiveness.

Clinic Visits, Costs Decreased by Rotavirus Vaccination in US Children

Clinic Visits, Costs Decreased by Rotavirus Vaccination in US Children

By

An analysis of the financial burden associated with rotavirus infection revealed a lower cost burden for children receiving complete and incomplete vaccination relative to completely unvaccinated children.

Otopathogen Prevalence Altered Since Pneumococcal Vaccine Introduction

Otopathogen Prevalence Altered Since Pneumococcal Vaccine Introduction

By

A new longitudinal study updates the epidemiology of acute otitis media in the decade after pneumococcal conjugate vaccine introduction.

Influenza Vaccine's Effectiveness Following Repeated Vaccination

Influenza Vaccine's Effectiveness Following Repeated Vaccination

By

Influenza vaccination is recommended annually because of antigenic drift, which warrants the change of influenza vaccine on a year-to-year basis.

Vaccine-Type HPV Rates Low in Unvaccinated Women

Vaccine-Type HPV Rates Low in Unvaccinated Women

From 2009-2010 to 2013-2014, there was a decrease in the prevalence of vaccine-type human papillomavirus among unvaccinated young women, which suggests they are beginning to benefit from herd immunity.

FDA: Tetanus and Diphtheria Vaccine Shortage Resolved

FDA: Tetanus and Diphtheria Vaccine Shortage Resolved

By

The FDA has updated its list of resolved CBER-regulated product shortages to alert the public that the tetanus and diphteria vaccine shortage has been resolves.

Guideline Update: Influenza Immunization Recommendations for 2017-2018

Guideline Update: Influenza Immunization Recommendations for 2017-2018

By

The trivalent, quadrivalent, and recombinant influenza vaccines will be available for use in the 2017-2018 flu season.

Seqirus Begins Shipping 2017-2018 Influenza Vaccines

Seqirus Begins Shipping 2017-2018 Influenza Vaccines

By

Both trivalent and quadrivalent formulations of the influenza vaccine will be offered by Seqirus, which were developed using egg- and cell-based technologies.

HPV Vaccine Does Not Increase Risk for Adverse Maternal, Infant Outcomes

HPV Vaccine Does Not Increase Risk for Adverse Maternal, Infant Outcomes

By

Inadvertent administration of the quadrivalent HPV vaccine during periconception or pregnancy was not associated with additional risk to mothers and their infants.

Influenza Vaccination Beneficial for Elderly With Asthma

Influenza Vaccination Beneficial for Elderly With Asthma

By

The flu vaccine may have benefits by reducing negative outcomes and mortality associated with contracting influenza.

HPV Vaccination Rates Lower Among Cancer Survivors

HPV Vaccination Rates Lower Among Cancer Survivors

By

Human papillomavirus vaccine initiation rates are low among young cancer survivors.

WHO: 12.9 Million Infants Go Unvaccinated Worldwide

WHO: 12.9 Million Infants Go Unvaccinated Worldwide

By

The World Health Organization reports that 12.9 million infants worldwide did not receive any vaccinations in 2016.

Hepatitis B: Search for the Cure and Challenges That Remain

Hepatitis B: Search for the Cure and Challenges That Remain

By

One of the main challenges in managing and controlling hepatitis B infection today is identifying people who are infected and ensuring that they have access to suitable treatment.

Chasing Serotype Replacement in Pneumococcal Pneumonia

Chasing Serotype Replacement in Pneumococcal Pneumonia

By

Increasing rates of non-pneumococcal conjugate vaccine 13 serotypes of invasive pneumococcal disease present a new challenge to the global containment of the infection.

Live Attenuated Influenza Vaccine in Children Ineffective During 2015-16 Season

Live Attenuated Influenza Vaccine in Children Ineffective During 2015-16 Season

By

The live attenuated influenza vaccine was ineffective among children between 2 and 17 years of age during the 2015-2016 season.

Rotavirus Vaccine Linked to Decrease In Pediatric Gastroenteritis Hospitalizations

Rotavirus Vaccine Linked to Decrease In Pediatric Gastroenteritis Hospitalizations

Implementation of rotavirus vaccination correlated with a reduction in acute gastroenteritis related hospitalization rates among children.

New WHO Guidelines for Hepatitis B Virus Vaccine

New WHO Guidelines for Hepatitis B Virus Vaccine

By

The World Health Organization published a position paper with updated recommendations on the use of the hepatitis B vaccine regarding target groups, immunization schedules, and storage and distribution.

Improving the Flu Vaccination Rate and Its Effect on Public Health

Improving the Flu Vaccination Rate and Its Effect on Public Health

By

Improving the rates of children and adult influenza vaccination could improve public health drastically.

Recurrent UTI Vaccine Granted FDA Fast Track Designation

Recurrent UTI Vaccine Granted FDA Fast Track Designation

By

FDA has granted Fast Track Designation to investigational vaccine for recurrent urinary track infection.

Prior Maternal Flu Vaccination Does Not Affect Newborn Antibody Titers

Prior Maternal Flu Vaccination Does Not Affect Newborn Antibody Titers

Prior influenza vaccination predicts higher baseline antibody titers and decreased peak antibody responses against all influenza strains in pregnant women.

Influenza Vaccination During Pregnancy Reduces Infant Risk for Acute Lower Respiratory Infection

Influenza Vaccination During Pregnancy Reduces Infant Risk for Acute Lower Respiratory Infection

By

Influenza vaccination during pregnancy decreases infant hospitalizations for all-cause acute lower respiratory tract infection during the first 3 months of life.

Acute Otitis Media Epidemiology Changed With Pneumococcal Vaccines

Acute Otitis Media Epidemiology Changed With Pneumococcal Vaccines

Since the introduction of pneumococcal vaccines, the epidemiology of acute otitis media has changed considerably.

Second Dose of Tetravalent Dengue Vaccine Candidate Shows Enhanced Immunogenicity

Second Dose of Tetravalent Dengue Vaccine Candidate Shows Enhanced Immunogenicity

By

A tetravalent dengue vaccine candidate (TDV) was found to be safe and immunogenic in an ongoing phase 2 trial. A second TDV dose induced enhanced immunogenicity against DENV-3 and DENV-4 in children who were seronegative before vaccination, supporting the initiation of phase 3 trial to evaluate the efficacy and safety of TDV given in a 2-dose schedule 3 months apart.

First Doses of Fluzone Vaccines Shipped for 2017-2018 Flu Season

First Doses of Fluzone Vaccines Shipped for 2017-2018 Flu Season

By

Sanofi Pasteur announced that the first doses of Fluzone for the upcoming 2017-2018 influenza season have been shipped.

 Vaccination Hesitancy May Result in 3-Fold Increase Measles Cases

Vaccination Hesitancy May Result in 3-Fold Increase Measles Cases

Researchers determined that just a 5% drop in MMR vaccine coverage could triple the number of measles cases ever year.

CDC Update: Total Depletion of Yellow Fever Vaccine in US

CDC Update: Total Depletion of Yellow Fever Vaccine in US

By

Sanofi Pasteur announced the total depletion of their stock of yellow fever vaccine YF-VAX.

FDA Approves Concomitant Use of Varicella Zoster and Influenza Vaccines

FDA Approves Concomitant Use of Varicella Zoster and Influenza Vaccines

By

The FDA has approved the concomitant use of varicella zoster vaccine and inactivated trivalent and quadrivalent influenza vaccines.

Single-Dose PCV13 Immunogenic, Safe in Pediatric Oncology

Single-Dose PCV13 Immunogenic, Safe in Pediatric Oncology

A single-dose 13-valent pneumococcal conjugate vaccine (PCV13) was found to be safe and immunogenic for pediatric oncology patients.

Voluntary Recall of Meningitis Vaccine

Voluntary Recall of Meningitis Vaccine

By

GlaxoSmithKline has initiated a voluntary recall of Menveo vaccine for meningitis for intramuscular injection.

Sign Up for Free e-newsletters